VKTX peer analysis
Viking Therapeutics (VKTX) against its competitors: price, today's move, 1-year return and market value side by side.
VKTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| KLRA Kailera Therapeutics | $12.13 | -5.64% | – | – |
| MBX MBX Biosciences | $54.34 | -2.74% | 149.38% | – |
| MDGL Madrigal Pharma | $430.59 | 0.05% | 0.72% | $9.94B |
| NAMS NewAmsterdam Pharma | $19.56 | -2.49% | -49.48% | – |
| SEPN Septerna | $43.32 | -1.55% | 101.58% | – |
| VTVT vTv Therapeutics | $25.17 | -4.59% | 20.49% | $99.52M |
| VKTX Viking Therapeutics | $26.92 | -1.32% | -29.47% | $3.48B |
- VKTX's peers: KLRA (Kailera Therapeutics), MBX (MBX Biosciences), MDGL (Madrigal Pharma), NAMS (NewAmsterdam Pharma), SEPN (Septerna), VTVT (vTv Therapeutics).
Updated 2026-11-03 02:49 UTC